Genomics

Dataset Information

0

Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma


ABSTRACT: Neuroblastomas are tumors of peripheral sympathetic neurons and are the most common solid tumor in children. To determine the genetic basis for neuroblastoma we performed whole-genome sequencing (6 cases), exome sequencing (16 cases), genome-wide rearrangement analyses (32 cases), and targeted analyses of specific genomic loci (40 cases) using massively parallel sequencing. On average each tumor had 19 somatic alterations in coding genes (range, 3-70). Among genes not previously known to be involved in neuroblastoma, chromosomal deletions and sequence alterations of chromatin remodeling genes, ARID1A and ARID1B, were identified in 8 of 71 tumors (11%) and were associated with early treatment failure and decreased survival. Using tumor-specific structural alterations, we developed an approach to identify rearranged DNA fragments in sera, providing personalized biomarkers for minimal residual disease detection and monitoring. These results highlight dysregulation of chromatin remodeling in pediatric tumorigenesis and provide new approaches for the management of neuroblastoma patients. Data Provider: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center (SKCCC)

PROVIDER: EGAS00001000369 | EGA |

REPOSITORIES: EGA

altmetric image

Publications


Neuroblastomas are tumors of peripheral sympathetic neurons and are the most common solid tumor in children. To determine the genetic basis for neuroblastoma, we performed whole-genome sequencing (6 cases), exome sequencing (16 cases), genome-wide rearrangement analyses (32 cases) and targeted analyses of specific genomic loci (40 cases) using massively parallel sequencing. On average, each tumor had 19 somatic alterations in coding genes (range of 3-70). Among genes not previously known to be i  ...[more]

Similar Datasets

| EGAD00001000282 | EGA
2022-11-01 | GSE202231 | GEO
| EGAS00001000941 | EGA
2020-07-20 | GSE134631 | GEO
2020-07-20 | GSE134626 | GEO
2016-11-12 | GSE75291 | GEO
2014-09-29 | ST000104 | MetabolomicsWorkbench
2022-11-01 | GSE202306 | GEO
2022-07-21 | GSE203249 | GEO
2022-07-21 | GSE203214 | GEO